Knockdown of CD47 suppressed certain stem‐like properties of cancer cells, such as self‐renewal and chemoresistance,14, 15, 16, 17 suggesting that targeting CD47 could not only active the phagocytosis of macrophages, but also be refined into a potent supplement in treatment against CSCs. The gene discussed is CD47; the disease is cancer.